Screener
Nurix Therapeutics, Inc. NRIX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Nurix Therapeutics, Inc.’s 8-K, filed July 9, 2026. Open the filing →
- Filed
- Jul 9, 2026, 4:09 PM EDT
- Accession
- 0001549595-26-000038
FAQ
- What is Nurix Therapeutics, Inc.'s current ratio?
- Nurix Therapeutics, Inc. (NRIX) reported current ratio of 6.3× in Q1 2026.
- How has Nurix Therapeutics, Inc.'s current ratio changed year-over-year?
- Nurix Therapeutics, Inc.'s current ratio decreased by 7.0% year-over-year, from 6.8× to 6.3×.
- What is the long-term trend for Nurix Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s current ratio has grown at a 0.9% compound annual growth rate (CAGR), from 6.7× to 7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Nurix Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude